发明名称 |
PHARMACEUTICAL FORMULATIONS FOR CARRIER-MEDIATED TRANSPORT STATINS AND USES THEREOF |
摘要 |
The present invention relates to formulations comprising therapeutically effective amounts of at least one acid-stable, carrier-mediated transport statin, at least one poorly water-soluble, carrier-mediated transport statin, or at least one large molecular weight, carrier-mediated transport statin, such as atorvastatin and rosuvastatin, or a pharmaceutically acceptable salt thereof, and methods of their use. The present formulations and methods are designed to exhibit a controlled-release of a therapeutic amount of the statin in the small intestine, thereby limiting systemic exposure of the statin and maximizing liver-specific absorption of the drug. The formulations and methods of the present invention are particularly useful for treating and/or preventing conditions that are benefited by decreasing levels of lipids and/or cholesterol in the body. |
申请公布号 |
US2015164893(A1) |
申请公布日期 |
2015.06.18 |
申请号 |
US201514629232 |
申请日期 |
2015.02.23 |
申请人 |
Circ Pharma Research and Development Limited |
发明人 |
Butler Jackie;Devane John;Stark Paul |
分类号 |
A61K31/505;A61K31/40 |
主分类号 |
A61K31/505 |
代理机构 |
|
代理人 |
|
主权项 |
1. A method of increasing the hepatic bioavailability of at least one acid-stable, carrier-mediated transport statin, comprising administering to a subject a therapeutically effective amount of the at least one acid-stable, carrier-mediated transport statin, or a pharmaceutically acceptable salt thereof, in a pharmaceutical formulation, wherein the formulation releases the statin at a rate that avoids saturating the intestinal and hepatocytic absorption mechanisms. |
地址 |
Dublin IE |